{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:35:34Z","timestamp":1774992934071,"version":"3.50.1"},"reference-count":171,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T00:00:00Z","timestamp":1637366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T00:00:00Z","timestamp":1637366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PD\/BD\/114257\/2016"],"award-info":[{"award-number":["PD\/BD\/114257\/2016"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/131331\/2017"],"award-info":[{"award-number":["SFRH\/BD\/131331\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/MED-TOX\/30418\/2017"],"award-info":[{"award-number":["PTDC\/MED-TOX\/30418\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00109-021-02163-2","type":"journal-article","created":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T09:02:32Z","timestamp":1637398952000},"page":"215-243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Pharmacological blockage of the AHR-CYP1A1 axis: a call for in vivo evidence"],"prefix":"10.1007","volume":"100","author":[{"given":"N. R.","family":"Coelho","sequence":"first","affiliation":[]},{"given":"A. B.","family":"Pimp\u00e3o","sequence":"additional","affiliation":[]},{"given":"M. J.","family":"Correia","sequence":"additional","affiliation":[]},{"given":"T. C.","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"E. C.","family":"Monteiro","sequence":"additional","affiliation":[]},{"given":"J.","family":"Morello","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8456-9995","authenticated-orcid":false,"given":"S. A.","family":"Pereira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,11,20]]},"reference":[{"key":"2163_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0304-4165(02)00485-3","volume":"1619","author":"J Mimura","year":"2003","unstructured":"Mimura J, Fujii-Kuriyama Y (2003) Functional role of AhR in the expression of toxic effects by TCDD. Biochim Biophys Acta - Gen Subj 1619:263\u2013268. https:\/\/doi.org\/10.1016\/S0304-4165(02)00485-3","journal-title":"Biochim Biophys Acta - Gen Subj"},{"key":"2163_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.plipres.2017.06.001","volume":"67","author":"DW Nebert","year":"2017","unstructured":"Nebert DW (2017) Aryl hydrocarbon receptor (AHR): \u201cpioneer member\u201d of the basic-helix\/loop\/helix per-Arnt-sim (bHLH\/PAS) family of \u201csensors\u201d of foreign and endogenous signals. Prog Lipid Res 67:38\u201357. https:\/\/doi.org\/10.1016\/j.plipres.2017.06.001","journal-title":"Prog Lipid Res"},{"key":"2163_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/toxsci\/kfr218","volume":"124","author":"MS Denison","year":"2011","unstructured":"Denison MS, Soshilov AA, He G, Degroot DE, Zhao B (2011) Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor, toxicol. Sci 124:1\u201322. https:\/\/doi.org\/10.1093\/toxsci\/kfr218","journal-title":"Sci"},{"key":"2163_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biopen.2018.05.001","volume":"7","author":"L Larigot","year":"2018","unstructured":"Larigot L, Juricek L, Dairou J, Coumoul X (2018) AhR signaling pathways and regulatory functions. Biochim Open 7:1\u20139. https:\/\/doi.org\/10.1016\/j.biopen.2018.05.001","journal-title":"Biochim Open"},{"key":"2163_CR5","doi-asserted-by":"publisher","unstructured":"Degroot D, He G, Fraccalvieri D, Bonati L, Pandini AA, Denison MS (2011) AHR Ligands: promiscuity in Binding and Diversity in Response, in: AH Recept. Biol. Toxicol., John Wiley and Sons, Hoboken, NJ, USA,\u00a0pp. 63\u201379. https:\/\/doi.org\/10.1002\/9781118140574.ch4","DOI":"10.1002\/9781118140574.ch4"},{"key":"2163_CR6","doi-asserted-by":"publisher","unstructured":"Yi T, Wang J, Zhu K, Tang Y, Huang S, Shui X, Ding Y, Chen C, Lei W (2018)\u00a0Aryl Hydrocarbon receptor: a new player of pathogenesis and therapy in cardiovascular diseases. Biomed Res Int\u00a02018. https:\/\/doi.org\/10.1155\/2018\/6058784","DOI":"10.1155\/2018\/6058784"},{"key":"2163_CR7","doi-asserted-by":"publisher","unstructured":"Correia MJ, Pimp\u00e3o AB, Lopes-Coelho F, Sequeira CO, Coelho NR, Gon\u00e7alves-Dias C, Barouki R, Coumoul X, Serpa J, Morello J, Monteiro EC, Pereira SA (2021)\u00a0Aryl hydrocarbon receptor and cysteine redox dynamics underlie (mal)adaptive mechanisms to chronic intermittent hypoxia in kidney cortex, antioxidants. 10:1484. https:\/\/doi.org\/10.3390\/ANTIOX10091484","DOI":"10.3390\/ANTIOX10091484"},{"key":"2163_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1021\/tx7001965","volume":"21","author":"LP Nguyen","year":"2008","unstructured":"Nguyen LP, Bradfield CA (2008) The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol 21:102\u2013116. https:\/\/doi.org\/10.1021\/tx7001965","journal-title":"Chem Res Toxicol"},{"key":"2163_CR9","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1124\/dmd.115.064246","volume":"43","author":"TD Hubbard","year":"2015","unstructured":"Hubbard TD, Murray IA, Perdew GH (2015) Indole and tryptophan metabolism: endogenous and dietary routes to ah receptor activation. Drug Metab Dispos 43:1522\u20131535. https:\/\/doi.org\/10.1124\/dmd.115.064246","journal-title":"Drug Metab Dispos"},{"key":"2163_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1515\/dmdi-2011-0035","volume":"27","author":"R Barouki","year":"2012","unstructured":"Barouki R, Aggerbeck M, Aggerbeck L, Coumoul X (2012) The aryl hydrocarbon receptor system. Drug Metabol Drug Interact 27:3\u20138. https:\/\/doi.org\/10.1515\/dmdi-2011-0035","journal-title":"Drug Metabol Drug Interact"},{"key":"2163_CR11","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.drudis.2012.11.014","volume":"18","author":"E Guyot","year":"2013","unstructured":"Guyot E, Chevallier A, Barouki R, Coumoul X (2013) The AhR twist: ligand-dependent AhR signaling and pharmaco-toxicological implications. Drug Discov Today 18:479\u2013486. https:\/\/doi.org\/10.1016\/j.drudis.2012.11.014","journal-title":"Drug Discov Today"},{"key":"2163_CR12","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1124\/mol.106.032748","volume":"71","author":"W Hu","year":"2007","unstructured":"Hu W, Sorrentino C, Denison MS, Kolaja K, Fielden MR (2007) Induction of Cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro. Mol Pharmacol 71:1475\u20131486. https:\/\/doi.org\/10.1124\/mol.106.032748","journal-title":"Mol Pharmacol"},{"key":"2163_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1101\/gad.13.1.20","volume":"13","author":"J Mimura","year":"1999","unstructured":"Mimura J, Ema M, Sogawa K, Fujii-Kuriyama Y (1999) Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes Dev 13:20\u201325. https:\/\/doi.org\/10.1101\/gad.13.1.20","journal-title":"Genes Dev"},{"key":"2163_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1124\/jpet.113.203786","volume":"345","author":"SR Wilson","year":"2013","unstructured":"Wilson SR, Joshi AD, Elferink CJ (2013) The tumor suppressor Kruppel-like factor 6 is a novel aryl hydrocarbon receptor DNA binding partner. J Pharmacol Exp Ther 345:419\u2013429. https:\/\/doi.org\/10.1124\/jpet.113.203786","journal-title":"J Pharmacol Exp Ther"},{"key":"2163_CR15","doi-asserted-by":"publisher","unstructured":"Oesch-Bartlomowicz B, Huelster A, Wiss O, Antoniou-Lipfert P, Dietrich C, Arand M, Weiss C, Bockamp E, Oesch F (2005)\u00a0Aryl hydrocarbon receptor activation by cAMP vs. dioxin: divergent signaling pathways. Proc Natl Acad Sci USA 102:9218\u20139223. https:\/\/doi.org\/10.1073\/pnas.0503488102","DOI":"10.1073\/pnas.0503488102"},{"key":"2163_CR16","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1073\/pnas.0607296104","volume":"104","author":"BJ McMillan","year":"2007","unstructured":"McMillan BJ, Bradfield CA (2007) The aryl hydrocarbon receptor is activated by modified low-density lipoprotein. Proc Natl Acad Sci U S A 104:1412\u20131417. https:\/\/doi.org\/10.1073\/pnas.0607296104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2163_CR17","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/cvr\/cvm095","volume":"77","author":"Z Han","year":"2008","unstructured":"Han Z, Miwa Y, Obikane H, Mitsumata M, Takahashi-Yanaga F, Morimoto S, Sasaguri T (2008) Aryl hydrocarbon receptor mediates laminar fluid shear stress-induced CYP1A1 activation and cell cycle arrest in vascular endothelial cells. Cardiovasc Res 77:809\u2013818. https:\/\/doi.org\/10.1093\/cvr\/cvm095","journal-title":"Cardiovasc Res"},{"key":"2163_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.toxlet.2015.02.005","volume":"233","author":"W Xiao","year":"2015","unstructured":"Xiao W, Son J, Vorrink SU, Domann FE, Goswami PC (2015) Ligand-independent activation of aryl hydrocarbon receptor signaling in PCB3-quinone treated HaCaT human keratinocytes. Toxicol Lett 233:258\u2013266. https:\/\/doi.org\/10.1016\/j.toxlet.2015.02.005","journal-title":"Toxicol Lett"},{"key":"2163_CR19","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1210\/en.2003-0192","volume":"144","author":"AJ Lee","year":"2003","unstructured":"Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT (2003) Characterization of the oxidative metabolites of 17\u03b2-estradiol and estrone formed by 15 selectively expressed human cytochrome P450 isoforms. Endocrinology 144:3382\u20133398. https:\/\/doi.org\/10.1210\/en.2003-0192","journal-title":"Endocrinology"},{"key":"2163_CR20","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.bcp.2003.12.023","volume":"67","author":"D Schwarz","year":"2004","unstructured":"Schwarz D, Kisselev P, Ericksen SS, Szklarz GD, Chernogolov A, Honeck H, Schunck WH, Roots I (2004) Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid. Biochem Pharmacol 67:1445\u20131457. https:\/\/doi.org\/10.1016\/j.bcp.2003.12.023","journal-title":"Biochem Pharmacol"},{"key":"2163_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1124\/dmd.104.002410","volume":"33","author":"X Ma","year":"2005","unstructured":"Ma X, Idle JR, Krausz KW, Gonzalez FJ (2005) Metabolism of melatonin by human cytochromes P450. Drug Metab Dispos 33:489\u2013494. https:\/\/doi.org\/10.1124\/dmd.104.002410","journal-title":"Drug Metab Dispos"},{"key":"2163_CR22","doi-asserted-by":"crossref","unstructured":"Favreau LV, Pickett CB (1991)\u00a0Transcriptional regulation of the rat NAD(P)H:quinone reductase gene. Identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antioxidants. J Biol Chem 266:4556\u20134561. http:\/\/www.jbc.org\/ (accessed June 15, 2020)","DOI":"10.1016\/S0021-9258(20)64358-7"},{"key":"2163_CR23","doi-asserted-by":"publisher","first-page":"6874","DOI":"10.1016\/S0021-9258(19)50509-9","volume":"266","author":"AJ Watson","year":"1992","unstructured":"Watson AJ, Hankinson O (1992) Dioxin-and Ah Receptor-dependent protein binding to xenobiotic responsive elements and G-rich DNA studied by in vivo footprinting. J Biol Chem 266:6874\u20136878","journal-title":"J Biol Chem"},{"key":"2163_CR24","doi-asserted-by":"publisher","first-page":"33101","DOI":"10.1074\/jbc.M011497200","volume":"276","author":"T Baba","year":"2001","unstructured":"Baba T, Mimura J, Gradin K, Kuroiwa A, Watanabe T, Matsuda Y, Inazawa J, Sogawa K, Fujii-Kuriyama Y (2001) Structure and expression of the ah receptor repressor gene. J Biol Chem 276:33101\u201333110. https:\/\/doi.org\/10.1074\/jbc.M011497200","journal-title":"J Biol Chem"},{"key":"2163_CR25","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1096\/FJ.10-169227","volume":"25","author":"X Wang","year":"2011","unstructured":"Wang X, Hawkins BT, Miller DS (2011) Aryl hydrocarbon receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier. FASEB J 25:644. https:\/\/doi.org\/10.1096\/FJ.10-169227","journal-title":"FASEB J"},{"key":"2163_CR26","doi-asserted-by":"publisher","first-page":"28708","DOI":"10.1074\/jbc.274.40.28708","volume":"274","author":"NA Davarinos","year":"1999","unstructured":"Davarinos NA, Pollenz RS (1999) Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via the cytosplasmic proteasome following nuclear export. J Biol Chem 274:28708\u201328715. https:\/\/doi.org\/10.1074\/jbc.274.40.28708","journal-title":"J Biol Chem"},{"key":"2163_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1476-069X-8-24","volume":"8","author":"E Akahoshi","year":"2009","unstructured":"Akahoshi E, Yoshimura S, Uruno S, Ishihara-Sugano M (2009) Effect of dioxins on regulation of tyrosine hydroxylase gene expression by aryl hydrocarbon receptor: a neurotoxicology study. Environ Heal A Glob Access Sci Source 8:24. https:\/\/doi.org\/10.1186\/1476-069X-8-24","journal-title":"Environ Heal A Glob Access Sci Source"},{"key":"2163_CR28","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/ng575","volume":"28","author":"T Matikainen","year":"2001","unstructured":"Matikainen T, Perez GI, Jurisicova A, Pru JK, Schlezinger JJ, Ryu HY, Laine J, Sakai T, Korsmeyer SJ, Casper RF, Sherr DH, Tilly JL (2001) Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat Genet 28:355\u2013360. https:\/\/doi.org\/10.1038\/ng575","journal-title":"Nat Genet"},{"key":"2163_CR29","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.bbrc.2004.06.177","volume":"321","author":"PC Boutros","year":"2004","unstructured":"Boutros PC, Moffat ID, Franc MA, Tijet N, Tuomisto J, Pohjanvirta R, Okey AB (2004) Dioxin-responsive AHRE-II gene battery: identification by phylogenetic footprinting. Biochem Biophys Res Commun 321:707\u2013715. https:\/\/doi.org\/10.1016\/j.bbrc.2004.06.177","journal-title":"Biochem Biophys Res Commun"},{"key":"2163_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104869","volume":"159","author":"NR Coelho","year":"2020","unstructured":"Coelho NR, Tomkiewicz C, Correia MJ, Gon\u00e7alves-Dias C, Barouki R, Pereira SA, Coumoul X, Monteiro EC (2020) First evidence of aryl hydrocarbon receptor as a druggable target in hypertension induced by chronic intermittent hypoxia. Pharmacol Res 159:104869. https:\/\/doi.org\/10.1016\/j.phrs.2020.104869","journal-title":"Pharmacol Res"},{"key":"2163_CR31","doi-asserted-by":"publisher","unstructured":"Coelho NR, Matos C, Pimp\u00e3o AB, Correia MJ, Sequeira CO, Morello J, Pereira SA, Monteiro EC (2021)\u00a0AHR canonical pathway: in vivo findings to support novel antihypertensive strategies. Pharmacol Res 105407. https:\/\/doi.org\/10.1016\/j.phrs.2020.105407","DOI":"10.1016\/j.phrs.2020.105407"},{"key":"2163_CR32","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nrc3621","volume":"13","author":"DC Bersten","year":"2013","unstructured":"Bersten DC, Sullivan AE, Peet DJ, Whitelaw ML (2013) BHLH-PAS proteins in cancer. Nat Rev Cancer 13:827\u2013841. https:\/\/doi.org\/10.1038\/nrc3621","journal-title":"Nat Rev Cancer"},{"key":"2163_CR33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/toxsci\/kfq217","volume":"117","author":"B Zhao","year":"2010","unstructured":"Zhao B, Degroot DE, Hayashi A, He G, Denison MS (2010) CH223191 Is a ligand-selective antagonist of the Ah (dioxin) receptor. Toxicol Sci 117:393\u2013403. https:\/\/doi.org\/10.1093\/toxsci\/kfq217","journal-title":"Toxicol Sci"},{"key":"2163_CR34","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/toxsci\/61.2.256","volume":"61","author":"DA Nazarenko","year":"2001","unstructured":"Nazarenko DA, Dertinger SD, Gasiewicz TA (2001) In vivo antagonism of AhR-mediated gene induction by 3-methoxy-4-nitroflavone in TCDD-responsive lacZ mice. Toxicol Sci 61:256\u2013264. https:\/\/doi.org\/10.1093\/toxsci\/61.2.256","journal-title":"Toxicol Sci"},{"key":"2163_CR35","doi-asserted-by":"publisher","unstructured":"Datta A, Bhasin N, Kim H, Ranjan M, Rider B, Abd Elmageed ZY, Mondal D, Agrawal KC, Abdel-Mageed AB (2015)\u00a0Selective targeting of FAK-Pyk2 axis by alpha-naphthoflavone abrogates doxorubicin resistance in breast cancer cells. Cancer Lett 362:25\u201335. https:\/\/doi.org\/10.1016\/j.canlet.2015.03.009","DOI":"10.1016\/j.canlet.2015.03.009"},{"key":"2163_CR36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.aquatox.2007.09.005","volume":"85","author":"AR Timme-Laragy","year":"2007","unstructured":"Timme-Laragy AR, Cockman CJ, Matson CW, Di Giulio RT (2007) Synergistic induction of AHR regulated genes in developmental toxicity from co-exposure to two model PAHs in zebrafish. Aquat Toxicol 85:241\u2013250. https:\/\/doi.org\/10.1016\/j.aquatox.2007.09.005","journal-title":"Aquat Toxicol"},{"key":"2163_CR37","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1161\/01.ATV.0000146530.24736.ce","volume":"24","author":"C Gou\u00e9dard","year":"2004","unstructured":"Gou\u00e9dard C, Barouki R, Morel Y (2004) Induction of the paraoxonase-1 gene expression by resveratrol, arterioscler. Thromb Vasc Biol 24:2378\u20132383. https:\/\/doi.org\/10.1161\/01.ATV.0000146530.24736.ce","journal-title":"Thromb Vasc Biol"},{"key":"2163_CR38","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2174\/138920111795470994","volume":"12","author":"L Stejskalova","year":"2011","unstructured":"Stejskalova L, Pavek P (2011) The function of cytochrome P450 1A1 enzyme (CYP1A1) and aryl hydrocarbon receptor (AhR) in the placenta. Curr Pharm Biotechnol 12:715\u2013730. https:\/\/doi.org\/10.2174\/138920111795470994","journal-title":"Curr Pharm Biotechnol"},{"key":"2163_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pharmthera.2018.02.012","volume":"187","author":"M Mescher","year":"2018","unstructured":"Mescher M, Haarmann-Stemmann T (2018) Modulation of CYP1A1 metabolism: from adverse health effects to chemoprevention and therapeutic options. Pharmacol Ther 187:71\u201387. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.02.012","journal-title":"Pharmacol Ther"},{"key":"2163_CR40","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1124\/mol.56.3.588","volume":"56","author":"JJ Schlezinger","year":"1999","unstructured":"Schlezinger JJ, White RD, Stegeman JJ (1999) Oxidative inactivation of cytochrome P-450 1A (CYP1A) stimulated by 3,3\u2019,4,4\u2019-tetrachlorobiphenyl: production of reactive oxygen by vertebrate CYP1As. Mol Pharmacol 56:588\u2013597. https:\/\/doi.org\/10.1124\/mol.56.3.588","journal-title":"Mol Pharmacol"},{"key":"2163_CR41","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3109\/03602539308993984","volume":"25","author":"AP Beresford","year":"1993","unstructured":"Beresford AP (1993) CYP1A1: Friend or foe? Drug Metab Rev 25:503\u2013517. https:\/\/doi.org\/10.3109\/03602539308993984","journal-title":"Drug Metab Rev"},{"key":"2163_CR42","doi-asserted-by":"crossref","unstructured":"Eugster HP, Probst M, W\u00fcrgler FE, Sengstag C (1993)\u00a0Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae. Drug Metab Dispos 21:43LP\u201349. http:\/\/dmd.aspetjournals.org\/content\/21\/1\/43.abstract","DOI":"10.1016\/S0090-9556(25)07334-9"},{"key":"2163_CR43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.canlet.2004.07.036","volume":"220","author":"M Stiborov\u00e1","year":"2005","unstructured":"Stiborov\u00e1 M, Mart\u00ednek V, R\u00fddlov\u00e1 H, Koblas T, Hodek P (2005) Expression of cytochrome P450 1A1 and its contribution to oxidation of a potential human carcinogen 1-phenylazo-2-naphthol (Sudan I) in human livers. Cancer Lett 220:145\u2013154. https:\/\/doi.org\/10.1016\/j.canlet.2004.07.036","journal-title":"Cancer Lett"},{"key":"2163_CR44","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/jat.2968","volume":"34","author":"S Badal","year":"2014","unstructured":"Badal S, Delgoda R (2014) Role of the modulation of CYP1A1 expression and activity in chemoprevention. J Appl Toxicol 34:743\u2013753. https:\/\/doi.org\/10.1002\/jat.2968","journal-title":"J Appl Toxicol"},{"key":"2163_CR45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jsbmb.2014.11.003","volume":"147","author":"RE Go","year":"2015","unstructured":"Go RE, Hwang KA, Choi KC (2015) Cytochrome P450 1 family and cancers. J Steroid Biochem Mol Biol 147:24\u201330. https:\/\/doi.org\/10.1016\/j.jsbmb.2014.11.003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2163_CR46","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1124\/dmd.107.015826","volume":"35","author":"Q Ma","year":"2007","unstructured":"Ma Q, Lu AYH (2007) CYP1A induction and human risk assessment: An evolving tale of in vitro and in vivo studies. Drug Metab Dispos 35:1009\u20131016. https:\/\/doi.org\/10.1124\/dmd.107.015826","journal-title":"Drug Metab Dispos"},{"key":"2163_CR47","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1021\/acs.jcim.7b00095","volume":"57","author":"P Joshi","year":"2017","unstructured":"Joshi P, McCann GJP, Sonawane VR, Vishwakarma RA, Chaudhuri B, Bharate SB (2017) Identification of potent and selective CYP1A1 inhibitors via combined ligand and structure-based virtual screening and their in vitro validation in sacchrosomes and live human cells. J Chem Inf Model 57:1309\u20131320. https:\/\/doi.org\/10.1021\/acs.jcim.7b00095","journal-title":"J Chem Inf Model"},{"key":"2163_CR48","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/J.EJPS.2015.11.019","volume":"82","author":"AT Marinho","year":"2016","unstructured":"Marinho AT, Dias CG, Pinheiro PF, Lemos AR, Antunes AMM, Marques MM, Monteiro EC, Miranda JP, Pereira SA (2016) Nevirapine modulation of paraoxonase-1 in the liver: an in vitro three-model approach. Eur J Pharm Sci 82:147\u2013153. https:\/\/doi.org\/10.1016\/J.EJPS.2015.11.019","journal-title":"Eur J Pharm Sci"},{"key":"2163_CR49","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00204-016-1792-x","volume":"91","author":"PF Pinheiro","year":"2016","unstructured":"Pinheiro PF, Pereira SA, Harjivan SG, Martins IL, Marinho AT, Cipriano M, Jacob CC, Oliveira NG, Castro MF, Marques MM, Antunes AMM, Miranda JP (2016) Hepatocyte spheroids as a competent in vitro system for drug biotransformation studies: nevirapine as a bioactivation case study. Arch Toxicol 91:1199\u20131211. https:\/\/doi.org\/10.1007\/s00204-016-1792-x","journal-title":"Arch Toxicol"},{"key":"2163_CR50","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1006\/abbi.1995.1062","volume":"316","author":"YF Lu","year":"1995","unstructured":"Lu YF, Santostefano M, Cunningham BDM, Threadgill MD, Safe S (1995) Identification of 3\u2019-methoxy-4\u2019-nitroflavone as a pure aryl hydrocarbon (Ah) receptor antagonist and evidence for more than one form of the nuclear Ah receptor in MCF-7 human breast cancer cells. Arch Biochem Biophys 316:470\u2013477. https:\/\/doi.org\/10.1006\/abbi.1995.1062","journal-title":"Arch Biochem Biophys"},{"key":"2163_CR51","doi-asserted-by":"publisher","unstructured":"Dertinger SD, Lantum HBM, Silverstone AE, Gasiewicz TA (2000)\u00a0Effect of 3\u2019-methoxy-4\u2019-nitroflavone on benzo[a]pyrene toxicity. Aryl hydrocarbon receptor-dependent and -independent mechanisms. Biochem Pharmacol 60:189\u2013196. https:\/\/doi.org\/10.1016\/S0006-2952(00)00314-2","DOI":"10.1016\/S0006-2952(00)00314-2"},{"key":"2163_CR52","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/carcin\/22.1.171","volume":"22","author":"SD Dertinger","year":"2001","unstructured":"Dertinger SD, Nazarenko DA, Silverstone AE, Gasiewicz TA (2001) Aryl hydrocarbon receptor signaling plays a significant role in mediating benzo[a]pyrene-and cigarette smoke condensate-induced cytogenetic damage in vivo. Carcinogenesis 22:171\u2013177. https:\/\/doi.org\/10.1093\/carcin\/22.1.171","journal-title":"Carcinogenesis"},{"key":"2163_CR53","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1038\/jid.2013.221","volume":"133","author":"F Navid","year":"2013","unstructured":"Navid F, Bruhs A, Schuller W, Fritsche E, Krutmann J, Schwarz T, Schwarz A (2013) The aryl hydrocarbon receptor is involved in UVR-Induced immunosuppression. J Invest Dermatol 133:2763\u20132770. https:\/\/doi.org\/10.1038\/jid.2013.221","journal-title":"J Invest Dermatol"},{"key":"2163_CR54","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0960-0760(93)90228-O","volume":"46","author":"DR Campbell","year":"1993","unstructured":"Campbell DR, Kurzer MS (1993) Flavonoid inhibition of aromatase enzyme activity in human preadipocytes. J Steroid Biochem Mol Biol 46:381\u2013388. https:\/\/doi.org\/10.1016\/0960-0760(93)90228-O","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2163_CR55","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1021\/tx980090+","volume":"11","author":"T Shimada","year":"1998","unstructured":"Shimada T, Yamazaki H, Foroozesh M, Hopkins NE, Alworth WL, Guengerich FP (1998) Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1. Chem Res Toxicol 11:1048\u20131056. https:\/\/doi.org\/10.1021\/tx980090+","journal-title":"Chem Res Toxicol"},{"key":"2163_CR56","doi-asserted-by":"publisher","first-page":"12932","DOI":"10.1074\/jbc.M113.452953","volume":"288","author":"AA Walsh","year":"2013","unstructured":"Walsh AA, Szklarz GD, Scott EE (2013) Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism. J Biol Chem 288:12932\u201312943. https:\/\/doi.org\/10.1074\/jbc.M113.452953","journal-title":"J Biol Chem"},{"key":"2163_CR57","doi-asserted-by":"publisher","first-page":"14348","DOI":"10.1074\/jbc.M611692200","volume":"282","author":"S Sansen","year":"2007","unstructured":"Sansen S, Yano JK, Reynald RL, Schoch GA, Griffin KJ, Stout CD, Johnson EF (2007) Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2. J Biol Chem 282:14348\u201314355. https:\/\/doi.org\/10.1074\/jbc.M611692200","journal-title":"J Biol Chem"},{"key":"2163_CR58","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.1074\/jbc.M110.204420","volume":"286","author":"A Wang","year":"2011","unstructured":"Wang A, Savas U, Stout CD, Johnson EF (2011) Structural characterization of the complex between \u03b1-naphthoflavone and human cytochrome P450 1B1. J Biol Chem 286:5736\u20135743. https:\/\/doi.org\/10.1074\/jbc.M110.204420","journal-title":"J Biol Chem"},{"key":"2163_CR59","doi-asserted-by":"publisher","unstructured":"Sineva EV, Rumfeldt JAO, Halpert JR, Davydov DR (2013)\u00a0A large-scale allosteric transition in cytochrome P450 3A4 revealed by luminescence resonance energy transfer (LRET). PLoS One 8. https:\/\/doi.org\/10.1371\/journal.pone.0083898","DOI":"10.1371\/journal.pone.0083898"},{"key":"2163_CR60","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.taap.2004.07.010","volume":"203","author":"KE Thompson","year":"2005","unstructured":"Thompson KE, Bourguet SM, Christian PJ, Benedict JC, Sipes IG, Flaws JA, Hoyer PB (2005) Differences between rats and mice in the involvement of the aryl hydrocarbon receptor in 4-vinylcyclohexene diepoxide-induced ovarian follicle loss. Toxicol Appl Pharmacol 203:114\u2013123. https:\/\/doi.org\/10.1016\/j.taap.2004.07.010","journal-title":"Toxicol Appl Pharmacol"},{"key":"2163_CR61","doi-asserted-by":"publisher","unstructured":"Jang JY, Shin S, il Choi B, Park D, Jeon JH, Hwang SY, Kim JC, Kim YB, Nahm SS (2007)\u00a0Antiteratogenic effects of \u03b1-naphthoflavone on 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposed mice in utero. Reprod Toxicol 24:303\u2013309. https:\/\/doi.org\/10.1016\/j.reprotox.2007.08.002","DOI":"10.1016\/j.reprotox.2007.08.002"},{"key":"2163_CR62","doi-asserted-by":"publisher","unstructured":"Moyer BJ, Rojas IY, Kerley-Hamilton JS, Hazlett HF, Nemani KV, Trask HW, West RJ, Lupien LE, Collins AJ, Ringelberg CS, Gimi B, Kinlaw WB, Tomlinson CR (2016)\u00a0Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2\/4, TGF\u03b2, and IDO1. Toxicol Appl Pharmacol 300:13\u201324. https:\/\/doi.org\/10.1016\/j.taap.2016.03.011","DOI":"10.1016\/j.taap.2016.03.011"},{"key":"2163_CR63","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.nutres.2017.06.002","volume":"44","author":"BJ Moyer","year":"2017","unstructured":"Moyer BJ, Rojas IY, Kerley-Hamilton JS, Nemani KV, Trask HW, Ringelberg CS, Gimi B, Demidenko E, Tomlinson CR (2017) Obesity and fatty liver are prevented by inhibition of the aryl hydrocarbon receptor in both female and male mice. Nutr Res 44:38\u201350. https:\/\/doi.org\/10.1016\/j.nutres.2017.06.002","journal-title":"Nutr Res"},{"key":"2163_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109287","volume":"118","author":"H Xia","year":"2019","unstructured":"Xia H, Zhu X, Zhang X, Jiang H, Li B, Wang Z, Li D, Jin Y (2019) Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice. Biomed Pharmacother 118:109287. https:\/\/doi.org\/10.1016\/j.biopha.2019.109287","journal-title":"Biomed Pharmacother"},{"key":"2163_CR65","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/J.JID.2020.11.024","volume":"141","author":"M Kyoreva","year":"2021","unstructured":"Kyoreva M, Li Y, Hoosenally M, Hardman-Smart J, Morrison K, Tosi I, Tolaini M, Barinaga G, Stockinger B, Mrowietz U, Nestle FO, Smith CH, Barker JN, Di Meglio P (2021) CYP1A1 Enzymatic activity influences skin inflammation via regulation of the AHR pathway. J Invest Dermatol 141:1563. https:\/\/doi.org\/10.1016\/J.JID.2020.11.024","journal-title":"J Invest Dermatol"},{"key":"2163_CR66","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1124\/mol.114.093369","volume":"86","author":"AJ Parks","year":"2014","unstructured":"Parks AJ, Pollastri MP, Hahn ME, Stanford EA, Novikov O, Franks DG, Haigh SE, Narasimhan S, Ashton TD, Hopper TG, Kozakov D, Beglov D, Vajda S, Schlezinger JJ, Sherr DH (2014) In silico identification of an aryl hydrocarbon receptor antagonist with biological activity in vitro and in vivo. Mol Pharmacol 86:593\u2013608. https:\/\/doi.org\/10.1124\/mol.114.093369","journal-title":"Mol Pharmacol"},{"key":"2163_CR67","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1152\/AJPRENAL.00442.2019","volume":"317","author":"LM Aguiniga","year":"2019","unstructured":"Aguiniga LM, Searl TJ, Rahman-Enyart A, Yaggie RE, Yang W, Schaeffer AJ, Klumpp DJ (2019) Acyloxyacyl hydrolase regulates voiding activity. Am J Physiol 317:289\u2013300. https:\/\/doi.org\/10.1152\/AJPRENAL.00442.2019","journal-title":"Am J Physiol"},{"key":"2163_CR68","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1124\/mol.105.021832","volume":"69","author":"SH Kim","year":"2006","unstructured":"Kim SH, Henry EC, Kim DK, Kim YH, Kum JS, Myoung SH, Lee TG, Kang JK, Gasiewicz TA, Sung HR, Suh PG (2006) Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o- tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor. Mol Pharmacol 69:1871\u20131878. https:\/\/doi.org\/10.1124\/mol.105.021832","journal-title":"Mol Pharmacol"},{"key":"2163_CR69","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1124\/mol.111.073643","volume":"81","author":"EY Choi","year":"2012","unstructured":"Choi EY, Lee H, Dingle RWC, Kim KB, Swanson HI (2012) Development of novel CH223191-based antagonists of the aryl hydrocarbon receptor. Mol Pharmacol 81:3\u201311. https:\/\/doi.org\/10.1124\/mol.111.073643","journal-title":"Mol Pharmacol"},{"key":"2163_CR70","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/eji.201445228","volume":"46","author":"I Monteleone","year":"2016","unstructured":"Monteleone I, Zorzi F, Marafini I, Di Fusco D, Dinallo V, Caruso R, Izzo R, Franz\u00e8 E, Colantoni A, Pallone F, Monteleone G (2016) Aryl hydrocarbon receptor-driven signals inhibit collagen synthesis in the gut. Eur J Immunol 46:1047\u20131057. https:\/\/doi.org\/10.1002\/eji.201445228","journal-title":"Eur J Immunol"},{"key":"2163_CR71","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5918587","author":"C Liu","year":"2020","unstructured":"Liu C, Li Y, Chen Y, Huang S, Wang X, Luo S, Su Y, Zhou L, Luo X (2020) Baicalein Restores the Balance of Th17\/Treg cells via aryl hydrocarbon receptor to attenuate colitis. Mediators Inflamm. https:\/\/doi.org\/10.1155\/2020\/5918587","journal-title":"Mediators Inflamm"},{"key":"2163_CR72","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1161\/CIRCULATIONAHA.114.011394","volume":"130","author":"MI Cuartero","year":"2014","unstructured":"Cuartero MI, Ballesteros I, De La Parra J, Harkin AL, Abautret-Daly A, Sherwin E, Fern\u00e1ndez-Salguero P, Corb\u00ed \u00c1L, Lizasoain I, Moro MA (2014) L-kynurenine\/aryl hydrocarbon receptor pathway mediates brain damage after experimental stroke. Circulation 130:2040\u20132051. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.011394","journal-title":"Circulation"},{"key":"2163_CR73","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3390\/CELLS10040718","volume":"10","author":"M Tanaka","year":"2021","unstructured":"Tanaka M, Fujikawa M, Oguro A, Itoh K, Vogel CFA, Ishihara Y (2021) Involvement of the microglial aryl hydrocarbon receptor in neuroinflammation and vasogenic edema after ischemic stroke. Cells 10:718. https:\/\/doi.org\/10.3390\/CELLS10040718","journal-title":"Cells"},{"key":"2163_CR74","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1165\/rcmb.2017-0260OC","volume":"58","author":"A Dean","year":"2017","unstructured":"Dean A, Gregorc T, Docherty CK, Harvey KY, Nilsen M, Morrell NW, MacLean MR (2017) Role of the aryl hydrocarbon receptor in sugen 5416-induced experimental pulmonary hypertension. Am J Respir Cell Mol Biol 58:320\u2013330. https:\/\/doi.org\/10.1165\/rcmb.2017-0260OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2163_CR75","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0378-4274(88)90070-7","volume":"42","author":"G L\u00f6froth","year":"1988","unstructured":"L\u00f6froth G, Rannug A (1988) Ah receptor ligands in tobacco smoke. Toxicol Lett 42:131\u2013136. https:\/\/doi.org\/10.1016\/0378-4274(88)90070-7","journal-title":"Toxicol Lett"},{"key":"2163_CR76","doi-asserted-by":"publisher","unstructured":"Rico de Souza A, Traboulsi H, Wang X, Fritz JH, Eidelman DH, Baglole CJ (2021)\u00a0The aryl hydrocarbon receptor attenuates acute cigarette smoke-induced airway neutrophilia independent of the dioxin response element. Front Immunol 0:274. https:\/\/doi.org\/10.3389\/FIMMU.2021.630427","DOI":"10.3389\/FIMMU.2021.630427"},{"key":"2163_CR77","doi-asserted-by":"publisher","unstructured":"Jia Y, Tao Y, Lv C, Xia Y, Wei Z, Dai Y (2019)\u00a0Tetrandrine enhances the ubiquitination and degradation of Syk through an AhR-c-src-c-Cbl pathway and consequently inhibits osteoclastogenesis and bone destruction in arthritis. Cell Death Dis 10. https:\/\/doi.org\/10.1038\/s41419-018-1286-2","DOI":"10.1038\/s41419-018-1286-2"},{"key":"2163_CR78","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/TOXSCI\/KFT236","volume":"137","author":"S Pierre","year":"2014","unstructured":"Pierre S, Chevallier A, Teixeira-Clerc F, Ambolet-Camoit A, Bui L-C, Bats A-S, Fournet J-C, Fernandez-Salguero P, Aggerbeck M, Lotersztajn S, Barouki R, Coumoul X (2014) Aryl hydrocarbon receptor\u2013dependent induction of liver fibrosis by dioxin. Toxicol Sci 137:114\u2013124. https:\/\/doi.org\/10.1093\/TOXSCI\/KFT236","journal-title":"Toxicol Sci"},{"key":"2163_CR79","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1177\/030098589703400609","volume":"34","author":"PM Fernandez-Salguero","year":"1997","unstructured":"Fernandez-Salguero PM, Ward JM, Sundberg JP, Gonzalez FJ (1997) Lesions of aryl-hydrocarbon receptor-deficient mice. Vet Pathol 34:605\u2013614. https:\/\/doi.org\/10.1177\/030098589703400609","journal-title":"Vet Pathol"},{"key":"2163_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/J.INTIMP.2020.106886","volume":"88","author":"Y Shi","year":"2020","unstructured":"Shi Y, Tang B, Yu J, Luo Y, Xiao Y, Pi Z, Tang R, Wang Y, Kanekura T, Zeng Z, Xiao R (2020) Aryl hydrocarbon receptor signaling activation in systemic sclerosis attenuates collagen production and is a potential antifibrotic target. Int Immunopharmacol 88:106886. https:\/\/doi.org\/10.1016\/J.INTIMP.2020.106886","journal-title":"Int Immunopharmacol"},{"key":"2163_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELLIMM.2020.104238","volume":"358","author":"S Yang","year":"2020","unstructured":"Yang S, Tan L, Chen Y, Liu A, Hong M, Peng Z (2020) DIM mitigates the development of experimental autoimmune encephalomyelitis by maintaining the stability and suppressive function of regulatory T cells. Cell Immunol 358:104238. https:\/\/doi.org\/10.1016\/J.CELLIMM.2020.104238","journal-title":"Cell Immunol"},{"key":"2163_CR82","doi-asserted-by":"publisher","DOI":"10.1002\/JBT.22821","volume":"35","author":"H Mohammadi","year":"2021","unstructured":"Mohammadi H, Daryabor G, Bahraman AG, Keshavarzi M, Kalantar K, Mohammadi-Bardbori A (2021) Aryl hydrocarbon receptor engagement during redox alteration determines the fate of CD4+ T cells in C57BL\/6 mice. J Biochem Mol Toxicol 35:e22821. https:\/\/doi.org\/10.1002\/JBT.22821","journal-title":"J Biochem Mol Toxicol"},{"key":"2163_CR83","doi-asserted-by":"publisher","unstructured":"Kunitomi C, Harada M, Kusamoto A, Azhary JM, Nose E, Koike H, Xu Z, Urata Y, Takahashi N, Wada-Hiraike O, Hirota Y, Koga K, Fujii T, Osuga Y (2021)\u00a0Induction of aryl hydrocarbon receptor in granulosa cells by endoplasmic reticulum stress contributes to pathology of polycystic ovary syndrome. Mol Hum Reprod 27. https:\/\/doi.org\/10.1093\/MOLEHR\/GAAB003","DOI":"10.1093\/MOLEHR\/GAAB003"},{"key":"2163_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/J.NEUROPHARM.2021.108490","volume":"187","author":"C Abuin-Mart\u00ednez","year":"2021","unstructured":"Abuin-Mart\u00ednez C, Vidal R, Guti\u00e9rrez-L\u00f3pez MD, P\u00e9rez-Hern\u00e1ndez M, Gim\u00e9nez-G\u00f3mez P, Morales-Puerto N, O\u2019Shea E, Colado MI (2021) Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon receptor. Neuropharmacology 187:108490. https:\/\/doi.org\/10.1016\/J.NEUROPHARM.2021.108490","journal-title":"Neuropharmacology"},{"key":"2163_CR85","doi-asserted-by":"publisher","unstructured":"de Castro LF, Ferreira MC, da Silva RM, de Blotta MHSL, L.N.A. Longhi, Mamoni RL (2013)\u00a0Characterization of the immune response in human paracoccidioidomycosis. J Infect 67:470\u2013485. https:\/\/doi.org\/10.1016\/J.JINF.2013.07.019","DOI":"10.1016\/J.JINF.2013.07.019"},{"key":"2163_CR86","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature06880","volume":"453","author":"FJ Quintana","year":"2008","unstructured":"Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, Bettelli E, Caccamo M, Oukka M, Weiner HL (2008) Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor. Nature 453:65\u201371. https:\/\/doi.org\/10.1038\/nature06880","journal-title":"Nature"},{"key":"2163_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-68322-6","volume":"10","author":"EF de Ara\u00fajo","year":"2020","unstructured":"de Ara\u00fajo EF, Preite NW, Veldhoen M, Loures FV, Calich VLG (2020) Pulmonary paracoccidioidomycosis in AhR deficient hosts is severe and associated with defective Treg and Th22 responses. Sci Rep 10:1\u201316. https:\/\/doi.org\/10.1038\/s41598-020-68322-6","journal-title":"Sci Rep"},{"key":"2163_CR88","doi-asserted-by":"publisher","unstructured":"de Ara\u00fajo EF, Loures FV, Preite NW, Feriotti C, AL Galdino N, Costa TA, Calich VLG (2021)\u00a0AhR Ligands modulate the differentiation of innate lymphoid cells and t helper cell subsets that control the severity of a pulmonary fungal infection. Front Immunol\u00a01277. https:\/\/doi.org\/10.3389\/FIMMU.2021.630938","DOI":"10.3389\/FIMMU.2021.630938"},{"key":"2163_CR89","doi-asserted-by":"publisher","unstructured":"Giovannoni F, Bosch I, Polonio CM, Torti MF, Wheeler MA, Li Z, Romorini L, Rodriguez Varela MS, Rothhammer V, Barroso A, Tjon EC, Sanmarco LM, Takenaka MC, Modaresi SMS, Guti\u00e9rrez-V\u00e1zquez C, Zanluqui NG, dos Santos NB, Munhoz CD, Wang Z, Damonte EB, Sherr D, Gehrke L, Peron JPS, Garcia CC, Quintana FJ (2020)\u00a0AHR is a Zika virus host factor and a candidate target for antiviral therapy. Nat Neurosci 23:939\u2013951. https:\/\/doi.org\/10.1038\/s41593-020-0664-0","DOI":"10.1038\/s41593-020-0664-0"},{"key":"2163_CR90","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41422-020-00435-z","volume":"30","author":"Y Liu","year":"2020","unstructured":"Liu Y, Lv J, Liu J, Li M, Xie J, Lv Q, Deng W, Zhou N, Zhou Y, Song J, Wang P, Qin C, Tong W-M, Huang B (2020) Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19. Cell Res 30:1078\u20131087. https:\/\/doi.org\/10.1038\/s41422-020-00435-z","journal-title":"Cell Res"},{"key":"2163_CR91","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1124\/jpet.110.178392","volume":"338","author":"KJ Smith","year":"2011","unstructured":"Smith KJ, Murray IA, Tanos R, Tellew J, Boitano AE, Bisson WH, Kolluri SK, Cooke MP, Perdew GH (2011) Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism. J Pharmacol Exp Ther 338:318\u2013327. https:\/\/doi.org\/10.1124\/jpet.110.178392","journal-title":"J Pharmacol Exp Ther"},{"key":"2163_CR92","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1111\/bph.12576","volume":"171","author":"Z-Z Fang","year":"2014","unstructured":"Fang Z-Z, Krausz KW, Nagaoka K, Tanaka N, Gowda K, Amin SG, Perdew GH, Gonzalez FJ (2014) In vivo effects of the pure aryl hydrocarbon receptor antagonist GNF-351 after oral administration are limited to the gastrointestinal tract. Br J Pharmacol 171:1735\u20131746. https:\/\/doi.org\/10.1111\/bph.12576","journal-title":"Br J Pharmacol"},{"key":"2163_CR93","doi-asserted-by":"publisher","unstructured":"Bonnefont-Rousselot D (2016)\u00a0Resveratrol and cardiovascular diseases. Nutrients 8. https:\/\/doi.org\/10.3390\/nu8050250","DOI":"10.3390\/nu8050250"},{"key":"2163_CR94","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.4161\/cc.7.8.5740","volume":"7","author":"KB Harikumar","year":"2008","unstructured":"Harikumar KB, Aggarwal BB (2008) Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7:1020\u20131035. https:\/\/doi.org\/10.4161\/cc.7.8.5740","journal-title":"Cell Cycle"},{"key":"2163_CR95","doi-asserted-by":"publisher","unstructured":"Marti N, Bouchoucha N, Sauter KS, Fl\u00fcck CE (2017)\u00a0Resveratrol inhibits androgen production of human adrenocortical H295R cells by lowering CYP17 and CYP21 expression and activities. PLoS One 12. https:\/\/doi.org\/10.1371\/journal.pone.0174224","DOI":"10.1371\/journal.pone.0174224"},{"key":"2163_CR96","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/toxsci\/kfp079","volume":"110","author":"SR Beedanagari","year":"2009","unstructured":"Beedanagari SR, Bebenek I, Bui P, Hankinson O (2009) Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes. Toxicol Sci 110:61\u201367. https:\/\/doi.org\/10.1093\/toxsci\/kfp079","journal-title":"Toxicol Sci"},{"key":"2163_CR97","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/jat.916","volume":"23","author":"A Revel","year":"2003","unstructured":"Revel A, Raanani H, Younglai E, Xu J, Rogers I, Han R, Savouret JF, Casper RF (2003) Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J Appl Toxicol 23:255\u2013261. https:\/\/doi.org\/10.1002\/jat.916","journal-title":"J Appl Toxicol"},{"key":"2163_CR98","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/mnfr.201000206","volume":"55","author":"NP Singh","year":"2011","unstructured":"Singh NP, Singh US, Nagarkatti M, Nagarkatti PS (2011) Resveratrol (3,5,4\u2019-trihydroxystilbene) protects pregnant mother and fetus from the immunotoxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Nutr Food Res 55:209\u2013219. https:\/\/doi.org\/10.1002\/mnfr.201000206","journal-title":"Mol Nutr Food Res"},{"key":"2163_CR99","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0890-6238(01)00149-6","volume":"15","author":"A Revel","year":"2001","unstructured":"Revel A, Raanani H, Younglai E, Xu J, Han R, Savouret JF, Casper RF (2001) Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects sperm from DNA damage and apoptosis caused by benzo(a)pyrene. Reprod Toxicol 15:479\u2013486. https:\/\/doi.org\/10.1016\/S0890-6238(01)00149-6","journal-title":"Reprod Toxicol"},{"key":"2163_CR100","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jnutbio.2016.04.003","volume":"34","author":"B Banerjee","year":"2016","unstructured":"Banerjee B, Nandi P, Chakraborty S, Raha S, Sen PC, Jana K (2016) Resveratrol ameliorates benzo(a)pyrene-induced testicular dysfunction and apoptosis: Involvement of p38 MAPK\/ATF2\/iNOS signaling. J Nutr Biochem 34:17\u201329. https:\/\/doi.org\/10.1016\/j.jnutbio.2016.04.003","journal-title":"J Nutr Biochem"},{"key":"2163_CR101","doi-asserted-by":"publisher","unstructured":"Banerjee B, Chakraborty S, Ghosh D, Raha S, Sen PC (2016)\u00a0Jana K, Benzo(a)pyrene induced p53 mediated male germ cell apoptosis: synergistic protective effects of curcumin and resveratrol. Front Pharmacol 7. https:\/\/doi.org\/10.3389\/fphar.2016.00245","DOI":"10.3389\/fphar.2016.00245"},{"key":"2163_CR102","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1071\/RD17180","volume":"30","author":"RP Erthal","year":"2018","unstructured":"Erthal RP, Siervo GEML, Silveira LTR, Scarano WR, Fernandes GSA (2018) Can resveratrol attenuate testicular damage in neonatal and adult rats exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin during gestation? Reprod Fertil Dev 30:442\u2013450. https:\/\/doi.org\/10.1071\/RD17180","journal-title":"Reprod Fertil Dev"},{"key":"2163_CR103","doi-asserted-by":"publisher","unstructured":"Silveira LTR, de Mello Santos T, Camora LF, Pinho CF, Anselmo-Franci JA, Domeniconi RF, Justulin LA, Barbisan LF, Scarano WR (2018)\u00a0Protective effect of resveratrol on urogenital sinus and prostate development in rats exposed in utero to TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin). Reprod Toxicol 83:82\u201392. https:\/\/doi.org\/10.1016\/j.reprotox.2018.06.012","DOI":"10.1016\/j.reprotox.2018.06.012"},{"key":"2163_CR104","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/toxsci\/kfy206","volume":"166","author":"J Ghosh","year":"2018","unstructured":"Ghosh J, Chowdhury AR, Srinivasan S, Chattopadhyay M, Bose M, Bhattacharya S, Raza H, Fuchs SY, Rustgi AK, Gonzalez FJ, Avadhani NG (2018) Cigarette smoke toxins-induced mitochondrial dysfunction and pancreatitis involves aryl hydrocarbon receptor mediated Cyp1 gene expression: protective effects of resveratrol. Toxicol Sci 166:428\u2013440. https:\/\/doi.org\/10.1093\/toxsci\/kfy206","journal-title":"Toxicol Sci"},{"key":"2163_CR105","doi-asserted-by":"publisher","unstructured":"eun Lee J, Cho SG, Ko SG, Ahrmad SA, Puga A, Kim K (2020)\u00a0Regulation of a long noncoding RNA MALAT1 by aryl hydrocarbon receptor in pancreatic cancer cells and tissues. Biochem Biophys Res Commun 532:563\u2013569. https:\/\/doi.org\/10.1016\/J.BBRC.2020.08.053","DOI":"10.1016\/J.BBRC.2020.08.053"},{"key":"2163_CR106","doi-asserted-by":"publisher","first-page":"16189","DOI":"10.1007\/s11356-020-08073-z","volume":"27","author":"MM Mokhtar","year":"2020","unstructured":"Mokhtar MM, Khidr EG, Shaban HM, Allam S, Elsadek BEM, Salama SA, Ali SS (2020) The effect of aryl hydrocarbon receptor ligands on gentamicin-induced nephrotoxicity in rats. Environ Sci Pollut Res 27:16189\u201316202. https:\/\/doi.org\/10.1007\/s11356-020-08073-z","journal-title":"Environ Sci Pollut Res"},{"key":"2163_CR107","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1177\/1933719114525271","volume":"21","author":"SC Amaya","year":"2014","unstructured":"Amaya SC, Savaris RF, Filipovic CJ, Wise JD, Hestermann E, Young SL, Lessey BA (2014) Resveratrol and endometrium: a closer look at an active ingredient of red wine using in vivo and in vitro models. Reprod Sci 21:1362\u20131369. https:\/\/doi.org\/10.1177\/1933719114525271","journal-title":"Reprod Sci"},{"key":"2163_CR108","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/mc.22095","volume":"54","author":"AJ Papoutsis","year":"2015","unstructured":"Papoutsis AJ, Selmin OI, Borg JL, Romagnolo DF (2015) Gestational exposure to the AhR agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin induces BRCA-1 promoter hypermethylation and reduces BRCA-1 expression in mammary tissue of rat offspring: Preventive effects of resveratrol. Mol Carcinog 54:261\u2013269. https:\/\/doi.org\/10.1002\/mc.22095","journal-title":"Mol Carcinog"},{"key":"2163_CR109","doi-asserted-by":"publisher","first-page":"16454","DOI":"10.3390\/ijms160716454","volume":"16","author":"K Wang","year":"2015","unstructured":"Wang K, Feng C, Li C, Yao J, Xie X, Gong L, Luan Y, Xing G, Zhu X, Qi X, Ren J (2015) Baicalin protects mice from aristolochic acid I-induced kidney injury by induction of CYP1A through the aromatic hydrocarbon receptor. Int J Mol Sci 16:16454\u201316468. https:\/\/doi.org\/10.3390\/ijms160716454","journal-title":"Int J Mol Sci"},{"key":"2163_CR110","doi-asserted-by":"publisher","unstructured":"Anandasadagopan SK, Singh NM, Raza H, Bansal S, Selvaraj V, Singh S, Chowdhury AR, Leu NA, Avadhani NG (2017)\u00a0\u03b2-naphthoflavone-induced mitochondrial respiratory damage in Cyp1 knockout mouse and in cell culture systems: attenuation by resveratrol treatment. Oxid Med Cell Longev\u00a02017. https:\/\/doi.org\/10.1155\/2017\/5213186","DOI":"10.1155\/2017\/5213186"},{"key":"2163_CR111","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.scitotenv.2017.02.152","volume":"587\u2013588","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Jiang R, An L, Wang H, Cheng S, Qiong S, Weng Y (2017) Benzo[a]pyrene impedes self-renewal and differentiation of mesenchymal stem cells and influences fracture healing. Sci Total Environ 587\u2013588:305\u2013315. https:\/\/doi.org\/10.1016\/j.scitotenv.2017.02.152","journal-title":"Sci Total Environ"},{"key":"2163_CR112","doi-asserted-by":"publisher","unstructured":"Liu W-C, Shyu J-F, Lin Y-F, Chiu H-W, Lim PS, Lu C-L, Zhen C-M, Hou Y-C, Chen P-H, Lu K-C (2020) Resveratrol rescue indoxyl sulfate-induced deterioration of osteoblastogenesis via the aryl hydrocarbon receptor \/MAPK pathway. Int J Mol Sci\u00a021:7483. https:\/\/doi.org\/10.3390\/IJMS21207483","DOI":"10.3390\/IJMS21207483"},{"key":"2163_CR113","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/mnfr.200500010","volume":"49","author":"E Wenzel","year":"2005","unstructured":"Wenzel E, Somoza V (2005) Metabolism and bioavailability of trans-resveratrol. Mol Nutr Food Res 49:472\u2013481. https:\/\/doi.org\/10.1002\/mnfr.200500010","journal-title":"Mol Nutr Food Res"},{"key":"2163_CR114","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00280-010-1525-4","volume":"68","author":"IM Kapetanovic","year":"2010","unstructured":"Kapetanovic IM, Muzzio M, Huang Z, Thompson TN, McCormick DL (2010) Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother Pharmacol 68:593\u2013601. https:\/\/doi.org\/10.1007\/s00280-010-1525-4","journal-title":"Cancer Chemother Pharmacol"},{"key":"2163_CR115","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1289\/ehp.1205421","volume":"121","author":"NA Baker","year":"2013","unstructured":"Baker NA, Karounos M, English V, Fang J, Wei Y, Stromberg A, Sunkara M, Morris AJ, Swanson HI, Cassis LA (2013) Coplanar polychlorinated biphenyls impair glucose homeostasis in lean C57BL\/6 mice and mitigate beneficial effects of weight loss on glucose homeostasis in obese mice. Environ Health Perspect 121:105\u2013110. https:\/\/doi.org\/10.1289\/ehp.1205421","journal-title":"Environ Health Perspect"},{"key":"2163_CR116","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/j.jnutbio.2013.08.009","volume":"24","author":"NA Baker","year":"2013","unstructured":"Baker NA, English V, Sunkara M, Morris AJ, Pearson KJ, Cassis LA (2013) Resveratrol protects against polychlorinated biphenyl-mediated impairment of glucose homeostasis in adipocytes. J Nutr Biochem 24:2168\u20132174. https:\/\/doi.org\/10.1016\/j.jnutbio.2013.08.009","journal-title":"J Nutr Biochem"},{"key":"2163_CR117","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.3390\/ijms19082459","volume":"19","author":"CN Hsu","year":"2018","unstructured":"Hsu CN, Lin YJ, Lu PC, Tain YL (2018) Maternal resveratrol therapy protects male rat offspring against programmed hypertension induced by TCDD and dexamethasone exposures: Is it relevant to aryl hydrocarbon receptor? Int J Mol Sci 19:2459. https:\/\/doi.org\/10.3390\/ijms19082459","journal-title":"Int J Mol Sci"},{"key":"2163_CR118","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.nutres.2013.07.016","volume":"33","author":"B Wang","year":"2013","unstructured":"Wang B, Sun J, Li X, Zhou Q, Bai J, Shi Y, Le G (2013) Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet-induced obesity. Nutr Res 33:971\u2013981. https:\/\/doi.org\/10.1016\/j.nutres.2013.07.016","journal-title":"Nutr Res"},{"key":"2163_CR119","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.3390\/ijms20184382","volume":"20","author":"CN Hsu","year":"2019","unstructured":"Hsu CN, Lin YJ, Tain YL (2019) Maternal exposure to bisphenol a combined with high-fat diet-induced programmed hypertension in adult male rat offspring: effects of resveratrol. Int J Mol Sci 20:4382. https:\/\/doi.org\/10.3390\/ijms20184382","journal-title":"Int J Mol Sci"},{"key":"2163_CR120","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1124\/jpet.109.158261","volume":"332","author":"IA Murray","year":"2010","unstructured":"Murray IA, Flaveny CA, DiNatale BC, Chairo CR, Schroeder JC, Kusnadi A, Perdew GH (2010) Antagonism of aryl hydrocarbon receptor signaling by 6,2\u2032,4\u2032- trimethoxyflavone. J Pharmacol Exp Ther 332:135\u2013144. https:\/\/doi.org\/10.1124\/jpet.109.158261","journal-title":"J Pharmacol Exp Ther"},{"key":"2163_CR121","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12974-019-1572-7","volume":"16","author":"WC Chen","year":"2019","unstructured":"Chen WC, Chang LH, Huang SS, Huang YJ, Chih CL, Kuo HC, Lee YH, Lee IH (2019) Aryl hydrocarbon receptor modulates stroke-induced astrogliosis and neurogenesis in the adult mouse brain. J Neuroinflammation 16:187. https:\/\/doi.org\/10.1186\/s12974-019-1572-7","journal-title":"J Neuroinflammation"},{"key":"2163_CR122","doi-asserted-by":"publisher","first-page":"14906","DOI":"10.1038\/s41598-020-72023-5","volume":"10","author":"J-I Kwon","year":"2020","unstructured":"Kwon J-I, Heo H, Ham SJ, Chae YJ, Lee D-W, Kim ST, Min J, Sung YS, Kim KW, Choi Y, Woo DC, Woo C-W (2020) Aryl hydrocarbon receptor antagonism before reperfusion attenuates cerebral ischaemia\/reperfusion injury in rats. Sci Rep 10:14906. https:\/\/doi.org\/10.1038\/s41598-020-72023-5","journal-title":"Sci Rep"},{"key":"2163_CR123","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1111\/BPH.15062","volume":"177","author":"H Miao","year":"2020","unstructured":"Miao H, Cao G, Wu X-Q, Chen Y-Y, Chen D-Q, Chen L, Vaziri ND, Feng Y-L, Su W, Gao Y, Zhuang S, Yu X-Y, Zhang L, Guo Y, Zhao Y-Y (2020) Identification of endogenous 1-aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation. Br J Pharmacol 177:3415\u20133435. https:\/\/doi.org\/10.1111\/BPH.15062","journal-title":"Br J Pharmacol"},{"key":"2163_CR124","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.1172\/JCI70712","volume":"128","author":"A Bianchi-Smiraglia","year":"2018","unstructured":"Bianchi-Smiraglia A, Bagati A, Fink EE, Affronti HC, Lipchick BC, Moparthy S, Long MD, Rosario SR, Lightman SM, Moparthy K, Wolff DW, Yun DH, Han Z, Polechetti A, Roll MV, Gitlin II, Leonova KI, Rowsam AM, Kandel ES, Gudkov AV, Bergsagel PL, Lee KP, Smiraglia DJ, Nikiforov MA (2018) Inhibition of the aryl hydrocarbon receptor\/polyamine biosynthesis axis suppresses multiple myeloma. J Clin Invest 128:4682\u20134696. https:\/\/doi.org\/10.1172\/JCI70712","journal-title":"J Clin Invest"},{"key":"2163_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-17750-z","volume":"11","author":"LF Campesato","year":"2020","unstructured":"Campesato LF, Budhu S, Tchaicha J, Weng C-H, Gigoux M, Cohen IJ, Redmond D, Mangarin L, Pourpe S, Liu C, Zappasodi R, Zamarin D, Cavanaugh J, Castro AC, Manfredi MG, McGovern K, Merghoub T, Wolchok JD (2020) Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine. Nat Commun 11:1\u201311. https:\/\/doi.org\/10.1038\/s41467-020-17750-z","journal-title":"Nat Commun"},{"key":"2163_CR126","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0027-5107(02)00212-9","volume":"508","author":"E Takahashi","year":"2002","unstructured":"Takahashi E, Fujita KI, Kamataki T, Arimoto-Kobayashi S, Okamoto K, Negishi T (2002) Inhibition of human cytochrome P450 1B1, 1A1 and 1A2 by antigenotoxic compounds, purpurin and alizarin. Mutat Res - Fundam Mol Mech Mutagen 508:147\u2013156. https:\/\/doi.org\/10.1016\/S0027-5107(02)00212-9","journal-title":"Mutat Res - Fundam Mol Mech Mutagen"},{"key":"2163_CR127","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/13590849762664","volume":"7","author":"J Zhang","year":"1997","unstructured":"Zhang J, Shen X (1997) Antioxidant activities of baicalin, green tea polyphenols and alizarin in vitro and in vivo. J Nutr Environ Med 7:79\u201390. https:\/\/doi.org\/10.1080\/13590849762664","journal-title":"J Nutr Environ Med"},{"key":"2163_CR128","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.mrgentox.2006.09.011","volume":"626","author":"E Takahashi","year":"2007","unstructured":"Takahashi E, Arimoto S, Okamoto K, Negishi T (2007) Enhancement of phase II enzyme activity by purpurin resulting in the suppression of MeIQx-DNA-adduct formation in mice. Mutat Res - Genet Toxicol Environ Mutagen 626:128\u2013134. https:\/\/doi.org\/10.1016\/j.mrgentox.2006.09.011","journal-title":"Mutat Res - Genet Toxicol Environ Mutagen"},{"key":"2163_CR129","doi-asserted-by":"publisher","first-page":"395","DOI":"10.4155\/fmc-2018-0515","volume":"11","author":"L Xu","year":"2019","unstructured":"Xu L, Xing M, Xu X, Saadeldeen FS, Liu Z, Wei J, Kang W (2019) Alizarin increase glucose uptake through PI3K\/Akt signaling and improve alloxan-induced diabetic mice, Future. Med Chem 11:395\u2013406. https:\/\/doi.org\/10.4155\/fmc-2018-0515","journal-title":"Med Chem"},{"key":"2163_CR130","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/S0006-2952(01)00806-1","volume":"62","author":"M Stiborov\u00e1","year":"2001","unstructured":"Stiborov\u00e1 M, Bieler CA, Wiessler M, Frei E (2001) The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts. Biochem Pharmacol 62:1675\u20131684. https:\/\/doi.org\/10.1016\/S0006-2952(01)00806-1","journal-title":"Biochem Pharmacol"},{"key":"2163_CR131","doi-asserted-by":"publisher","first-page":"8374","DOI":"10.1158\/0008-5472.CAN-04-2202","volume":"64","author":"M Stiborov\u00e1","year":"2004","unstructured":"Stiborov\u00e1 M, Sejbal J, Bo\u0159ek-Dohalsk\u00e1 L, Aimov\u00e1 D, Poljakov\u00e1 J, Forsterov\u00e1 K, Rupertov\u00e1 M, Wiesner J, Hude\u010dek J, Wiessler M, Frei E (2004) The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N2-oxide. Cancer Res 64:8374\u20138380. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-2202","journal-title":"Cancer Res"},{"key":"2163_CR132","doi-asserted-by":"publisher","first-page":"437","DOI":"10.5507\/bp.2005.076","volume":"149","author":"D Aimov\u00e1","year":"2005","unstructured":"Aimov\u00e1 D, Stiborov\u00e1 M (2005) Antitumor drug ellipticine inhibits the activaties of rat hepatic cytochromes P450. Biomed Pap 149:437\u2013440","journal-title":"Biomed Pap"},{"key":"2163_CR133","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1124\/dmd.107.016048","volume":"35","author":"D Aimov\u00e1","year":"2007","unstructured":"Aimov\u00e1 D, Svobodov\u00e1 L, Kotrbov\u00e1 V, Mr\u00e1zov\u00e1 B, Hodek P, Hude\u010dek J, V\u00e1clav\u00edkov\u00e1 R, Frei E, Stiborov\u00e1 M (2007) The anticancer drug ellipticine is a potent inducer of rat cytochromes P450 1A1 and 1A2, thereby modulating its own metabolism. Drug Metab Dispos 35:1926\u20131934. https:\/\/doi.org\/10.1124\/dmd.107.016048","journal-title":"Drug Metab Dispos"},{"key":"2163_CR134","doi-asserted-by":"publisher","unstructured":"Wu Y, Sadatmousavi P, Wang R, Lu S, Yuan YF, Chen P (2012) Self-assembling peptide-based nanoparticles enhance anticancer effect of ellipticine in vitro and in vivo. Int J Nanomedicine 7:3221\u20133233. https:\/\/doi.org\/10.2147\/IJN.S31858","DOI":"10.2147\/IJN.S31858"},{"key":"2163_CR135","doi-asserted-by":"publisher","unstructured":"Chen Q, Liu J, Zhuang Y, ping Bai L, Yuan Q, Zheng S, Liao K, Khan MA, Wu Q, Luo C, Liu L, Wang H, Li T (2019)\u00a0Identification of an IKK\u03b2 inhibitor for inhibition of inflammation in vivo and in vitro. Pharmacol Res 149:104440. https:\/\/doi.org\/10.1016\/j.phrs.2019.104440","DOI":"10.1016\/j.phrs.2019.104440"},{"key":"2163_CR136","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/mnfr.200600135","volume":"51","author":"R Mikstacka","year":"2007","unstructured":"Mikstacka R, Przybylska D, Rimando AM, Baer-Dubowska W (2007) Inhibition of human recombinant cytochromes P450 CYP1A1 and CYP1B1 by trans-resveratrol methyl ethers. Mol Nutr Food Res 51:517\u2013524. https:\/\/doi.org\/10.1002\/mnfr.200600135","journal-title":"Mol Nutr Food Res"},{"key":"2163_CR137","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jsps.2019.01.001","volume":"27","author":"AA Albassam","year":"2019","unstructured":"Albassam AA, Frye RF (2019) Effect of pterostilbene on in vitro drug metabolizing enzyme activity. Saudi Pharm J 27:406\u2013412. https:\/\/doi.org\/10.1016\/j.jsps.2019.01.001","journal-title":"Saudi Pharm J"},{"key":"2163_CR138","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1021\/acs.jnatprod.7b00384","volume":"81","author":"H Er\u00e4salo","year":"2018","unstructured":"Er\u00e4salo H, H\u00e4m\u00e4l\u00e4inen M, Lepp\u00e4nen T, M\u00e4ki-Opas I, Laavola M, Haavikko R, Yli-Kauhaluoma J, Moilanen E (2018) Natural stilbenoids have anti-inflammatory properties in vivo and down-regulate the production of inflammatory mediators NO, IL6, and MCP1 possibly in a PI3K\/Akt-dependent manner. J Nat Prod 81:1131\u20131142. https:\/\/doi.org\/10.1021\/acs.jnatprod.7b00384","journal-title":"J Nat Prod"},{"key":"2163_CR139","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12906-019-2756-5","volume":"19","author":"W Nam","year":"2019","unstructured":"Nam W, Nam SH, Kim SP, Levin C, Friedman M (2019) Anti-adipogenic and anti-obesity activities of purpurin in 3T3-L1 preadipocyte cells and in mice fed a high-fat diet. BMC Complement Altern Med 19:364. https:\/\/doi.org\/10.1186\/s12906-019-2756-5","journal-title":"BMC Complement Altern Med"},{"key":"2163_CR140","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4014\/jmb.0907.07022","volume":"20","author":"JK Kim","year":"2010","unstructured":"Kim JK, Kim N, Lim YH (2010) Evaluation of the antibacterial activity of rhapontigenin produced from rhapontin by biotransformation against Propionibacterium acnes. J Microbiol Biotechnol 20:82\u201387. https:\/\/doi.org\/10.4014\/jmb.0907.07022","journal-title":"J Microbiol Biotechnol"},{"key":"2163_CR141","first-page":"389","volume":"29","author":"YJ Chun","year":"2001","unstructured":"Chun YJ, Ryu SY, Jeong TC, Kim MY (2001) Mechanism-based inhibition of human cytochrome P450 1A1 by rhapontigenin. Drug Metab Dispos 29:389\u2013393","journal-title":"Drug Metab Dispos"},{"key":"2163_CR142","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.jep.2013.10.029","volume":"150","author":"C Cieniak","year":"2013","unstructured":"Cieniak C, Liu R, Fottinger A, Smiley SAM, Guerrero-Analco JA, Bennett SAL, Haddad PS, Cuerrier A, Saleem A, Arnason JT, Foster BC (2013) In vitro inhibition of metabolism but not transport of gliclazide and repaglinide by Cree medicinal plant extracts. J Ethnopharmacol 150:1087\u20131095. https:\/\/doi.org\/10.1016\/j.jep.2013.10.029","journal-title":"J Ethnopharmacol"},{"key":"2163_CR143","unstructured":"Roupe KA, Helms GL, Halls SC, Y\u00e1\u00f1ez JA, Davies NMT (2005) Graduate program, preparative enzymatic synthesis and HPLC Analysis of rhapontigenin: applications to metabolism, pharmacokinetics and anti-cancer studies. J Pharm Pharm Sci 8:374\u2013386. www.cspscanada.org (accessed July 9, 2020)"},{"key":"2163_CR144","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2174\/157488406775268246","volume":"1","author":"K Roupe","year":"2006","unstructured":"Roupe K, Remsberg C, Yanez J, Davies N (2006) Pharmacometrics of stilbenes: seguing towards the clinic. Curr Clin Pharmacol 1:81\u2013101. https:\/\/doi.org\/10.2174\/157488406775268246","journal-title":"Curr Clin Pharmacol"},{"key":"2163_CR145","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000496800","volume":"103","author":"Y Fan","year":"2019","unstructured":"Fan Y (2019) Cardioprotective effect of rhapontigenin in isoproterenol-induced myocardial infarction in a rat model. Pharmacology 103:291\u2013302. https:\/\/doi.org\/10.1159\/000496800","journal-title":"Pharmacology"},{"key":"2163_CR146","unstructured":"Asahina Y, Kashiwaki K (1915)\u00a0chemical constituents of the fruits of Evodia rutaecarpa. J Pharm Soc Jpn 1293"},{"key":"2163_CR147","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1124\/DMD.30.3.349","volume":"30","author":"Y-F Ueng","year":"2002","unstructured":"Ueng Y-F, Jan W-C, Lin L-C, Chen T-L, Guengerich FP, Chen C-F (2002) The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes. Drug Metab Dispos 30:349\u2013353. https:\/\/doi.org\/10.1124\/DMD.30.3.349","journal-title":"Drug Metab Dispos"},{"key":"2163_CR148","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0024-3205(01)01390-X","volume":"70","author":"YF Ueng","year":"2001","unstructured":"Ueng YF, Wang JJ, Lin LC, Park SS, Chen CF (2001) Induction of cytochrome P450-dependent monooxygenase in mouse liver and kidney by rutaecarpine, an alkaloid of the herbal drug Evodia rutaecarpa. Life Sci 70:207\u2013217. https:\/\/doi.org\/10.1016\/S0024-3205(01)01390-X","journal-title":"Life Sci"},{"key":"2163_CR149","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1211\/0022357055489","volume":"57","author":"Y-F Ueng","year":"2005","unstructured":"Ueng Y-F, Tsai T-H, Don M-J, Chen R-M, Chen T-L (2005) Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats. J Pharm Pharmacol 57:227\u2013232. https:\/\/doi.org\/10.1211\/0022357055489","journal-title":"J Pharm Pharmacol"},{"key":"2163_CR150","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00204-010-0548-2","volume":"84","author":"T Haarmann-Stemmann","year":"2010","unstructured":"Haarmann-Stemmann T, Sendker J, G\u00f6tz C, Krug N, Bothe H, Fritsche E, Proksch P, Abel J (2010) Regulation of dioxin receptor function by different beta-carboline alkaloids. Arch Toxicol 84:619\u2013629. https:\/\/doi.org\/10.1007\/s00204-010-0548-2","journal-title":"Arch Toxicol"},{"key":"2163_CR151","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.tox.2009.10.013","volume":"266","author":"EH Han","year":"2009","unstructured":"Han EH, Kim HG, Im JH, Jeong TC, Jeong HG (2009) Up-regulation of CYP1A1 by rutaecarpine is dependent on aryl hydrocarbon receptor and calcium. Toxicology 266:38\u201347. https:\/\/doi.org\/10.1016\/j.tox.2009.10.013","journal-title":"Toxicology"},{"key":"2163_CR152","doi-asserted-by":"publisher","unstructured":"Tian KM, Li JJ, Xu SW (2019) Rutaecarpine: a promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu). Pharmacol Res 141:541\u2013550. https:\/\/doi.org\/10.1016\/j.phrs.2018.12.019","DOI":"10.1016\/j.phrs.2018.12.019"},{"key":"2163_CR153","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0167-0115(03)00087-9","volume":"114","author":"CP Hu","year":"2003","unstructured":"Hu CP, Li NS, Xiao L, Deng HW, Li YJ (2003) Involvement of capsaicin-sensitive sensory nerves in cardioprotection of rutaecarpine in rats. Regul Pept 114:45\u201349. https:\/\/doi.org\/10.1016\/S0167-0115(03)00087-9","journal-title":"Regul Pept"},{"key":"2163_CR154","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00210-016-1240-8","volume":"389","author":"W-Q Li","year":"2016","unstructured":"Li W-Q, Li X-H, Du J, Zhang W, Li D, Xiong X-M, Li Y-J (2016) Rutaecarpine attenuates hypoxia-induced right ventricular remodeling in rats, Naunyn. Schmiedebergs. Arch Pharmacol 389:757\u2013767. https:\/\/doi.org\/10.1007\/s00210-016-1240-8","journal-title":"Arch Pharmacol"},{"key":"2163_CR155","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/FJC.0b013e3181579e7e","volume":"50","author":"XP Qin","year":"2007","unstructured":"Qin XP, Zeng SY, Li D, Chen QQ, Luo D, Zhang Z, Hu GY, Deng HW, Li YJ (2007) Calcitonin gene-related peptide-mediated depressor effect and inhibiting vascular hypertrophy of rutaecarpine in renovascular hypertensive rats. J Cardiovasc Pharmacol 50:654\u2013659. https:\/\/doi.org\/10.1097\/FJC.0b013e3181579e7e","journal-title":"J Cardiovasc Pharmacol"},{"key":"2163_CR156","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.peptides.2008.06.010","volume":"29","author":"D Li","year":"2008","unstructured":"Li D, Peng J, Xin HY, Luo D, Zhang YS, Zhou Z, Jiang DJ, Deng HW, Li YJ (2008) Calcitonin gene-related peptide-mediated antihypertensive and anti-platelet effects by rutaecarpine in spontaneously hypertensive rats. Peptides 29:1781\u20131788. https:\/\/doi.org\/10.1016\/j.peptides.2008.06.010","journal-title":"Peptides"},{"key":"2163_CR157","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1440-1681.2008.05136.x","volume":"36","author":"D Li","year":"2009","unstructured":"Li D, Zhang XJ, Chen L, Yang Z, Deng HW, Peng J, Li YJ (2009) Calcitonin gene-related peptide mediates the cardioprotective effects of rutaecarpine against ischaemia-reperfusion injury in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 36:662\u2013667. https:\/\/doi.org\/10.1111\/j.1440-1681.2008.05136.x","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2163_CR158","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1097\/HJH.0b013e3283399326","volume":"28","author":"Z Zhou","year":"2010","unstructured":"Zhou Z, Peng J, Wang CJ, Li D, Li TT, Hu CP, Chen XP, Li YJ (2010) Accelerated senescence of endothelial progenitor cells in hypertension is related to the reduction of calcitonin gene-related peptide. J Hypertens 28:931\u2013939. https:\/\/doi.org\/10.1097\/HJH.0b013e3283399326","journal-title":"J Hypertens"},{"key":"2163_CR159","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1194\/jlr.M044198","volume":"55","author":"Y Xu","year":"2014","unstructured":"Xu Y, Liu Q, Xu Y, Liu C, Wang X, He X, Zhu N, Liu J, Wu Y, Li Y, Li N, Feng T, Lai F, Zhang M, Hong B, Jiang JD, Si S (2014) Rutaecarpine suppresses atherosclerosis in ApoE-\/- mice through upregulating ABCA1 and SR-BI within RCT. J Lipid Res 55:1634\u20131647. https:\/\/doi.org\/10.1194\/jlr.M044198","journal-title":"J Lipid Res"},{"key":"2163_CR160","doi-asserted-by":"publisher","unstructured":"Xu Y, Chen XP, Zhang F, Hou HH, Zhang JY, Lin SX, Sun AS (2017) Rutaecarpine inhibits intimal hyperplasia in A balloon-injured rat artery model. Chin J Integr Med 24:429\u2013435. https:\/\/doi.org\/10.1007\/s11655-017-2900-3","DOI":"10.1007\/s11655-017-2900-3"},{"key":"2163_CR161","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/aps.2015.167","volume":"37","author":"XQ Nie","year":"2016","unstructured":"Nie XQ, Chen HH, Zhang JY, Zhang YJ, Yang JW, Pan HJ, Song WX, Murad F, He YQ, Bian K (2016) Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1\/PI3K\/Akt and AMPK\/ACC2 signaling pathways. Acta Pharmacol Sin 37:483\u2013496. https:\/\/doi.org\/10.1038\/aps.2015.167","journal-title":"Acta Pharmacol Sin"},{"key":"2163_CR162","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3892\/mmr.2017.6631","volume":"16","author":"C Wang","year":"2017","unstructured":"Wang C, Hao Z, Zhou J, Zhang L, Sun Y, Liang C (2017) Rutaecarpine alleviates renal ischemia reperfusion injury in rats by suppressing the JNK\/p38 MAPK signaling pathway and interfering with the oxidative stress response. Mol Med Rep 16:922\u2013928. https:\/\/doi.org\/10.3892\/mmr.2017.6631","journal-title":"Mol Med Rep"},{"key":"2163_CR163","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cotox.2017.01.008","volume":"2","author":"Z Wang","year":"2017","unstructured":"Wang Z, Monti S, Sherr DH (2017) The diverse and important contributions of the AHR to cancer and cancer immunity. Curr Opin Toxicol 2:93\u2013102. https:\/\/doi.org\/10.1016\/j.cotox.2017.01.008","journal-title":"Curr Opin Toxicol"},{"key":"2163_CR164","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2017.12.012","volume":"48","author":"C Guti\u00e9rrez-V\u00e1zquez","year":"2018","unstructured":"Guti\u00e9rrez-V\u00e1zquez C, Quintana FJ (2018) Regulation of the immune response by the aryl hydrocarbon receptor. Immunity 48:19\u201333. https:\/\/doi.org\/10.1016\/j.immuni.2017.12.012","journal-title":"Immunity"},{"key":"2163_CR165","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fimmu.2018.00286","volume":"9","author":"P Xue","year":"2018","unstructured":"Xue P, Fu J, Zhou Y (2018) The aryl hydrocarbon receptor and tumor immunity. Front Immunol 9:13. https:\/\/doi.org\/10.3389\/fimmu.2018.00286","journal-title":"Front Immunol"},{"key":"2163_CR166","unstructured":"A first-in-humans dose finding study for an aryl hydrocarbon receptor inhibitor (AhRi) in patients with advanced cancer (n.d.)\u00a0https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04069026?term=aryl&draw=2&rank=2 (accessed\u00a015 Dec 2020)"},{"key":"2163_CR167","unstructured":"IK-175 in patients with advanced or metastatic solid tumors and urothelial carcinoma (n.d.)\u00a0https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04200963?term=aryl&draw=2&rank=4 (accessed\u00a015 Dec 2020)"},{"key":"2163_CR168","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1038\/s41598-020-58737-6","volume":"10","author":"E Loro","year":"2020","unstructured":"Loro E, Sengupta K, Bogdanovich S, Whig K, Schultz DC, Huryn DM, Khurana TS (2020) High-throughput identification of post-transcriptional utrophin up-regulators for Duchenne muscle dystrophy (DMD) therapy. Sci Rep 10:2143. https:\/\/doi.org\/10.1038\/s41598-020-58737-6","journal-title":"Sci Rep"},{"key":"2163_CR169","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1002\/anie.201912392","volume":"59","author":"IVL Wilkinson","year":"2020","unstructured":"Wilkinson IVL, Perkins KJ, Dugdale H, Moir L, Vuorinen A, Chatzopoulou M, Squire SE, Monecke S, Lomow A, Geese M, Charles PD, Burch P, Tinsley JM, Wynne GM, Davies SG, Wilson FX, Rastinejad F, Mohammed S, Davies KE, Russell AJ (2020) Chemical proteomics and phenotypic profiling identifies the aryl hydrocarbon receptor as a molecular target of the utrophin modulator ezutromid. Angew Chemie Int Ed 59:2420\u20132428. https:\/\/doi.org\/10.1002\/anie.201912392","journal-title":"Angew Chemie Int Ed"},{"key":"2163_CR170","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/cpdd.642","volume":"8","author":"F Muntoni","year":"2019","unstructured":"Muntoni F, Tejura B, Spinty S, Roper H, Hughes I, Layton G, Davies KE, Harriman S, Tinsley J (2019) A phase 1b trial to assess the pharmacokinetics of ezutromid in pediatric Duchenne muscular dystrophy patients on a balanced diet. Clin Pharmacol Drug Dev 8:922\u2013933. https:\/\/doi.org\/10.1002\/cpdd.642","journal-title":"Clin Pharmacol Drug Dev"},{"key":"2163_CR171","unstructured":"Proof of concept study to assess activity and safety of SMT C1100 (Ezutromid) in boys with Duchenne muscular dystrophy (DMD) (n.d.)\u00a0https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT02858362?term=PhaseOut+DMD&rank=1 (accessed\u00a015 Dec 2020)"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-021-02163-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-021-02163-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-021-02163-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T10:41:11Z","timestamp":1744195271000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-021-02163-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,20]]},"references-count":171,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["2163"],"URL":"https:\/\/doi.org\/10.1007\/s00109-021-02163-2","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,20]]},"assertion":[{"value":"9 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}